1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Proteins and Peptides Revenue
1.4 Market Analysis by Type
1.4.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Linaclotide
1.4.3 Calcitonin
1.4.4 Insulin
1.4.5 Octreotide
1.5 Market by Application
1.5.1 Global Oral Proteins and Peptides Market Share by Application: 2021-2026
1.5.2 Gastric & Digestive Disorders
1.5.3 Bone Diseases
1.5.4 Diabetes
1.5.5 Hormonal Disorders
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Oral Proteins and Peptides Market
1.8.1 Global Oral Proteins and Peptides Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Oral Proteins and Peptides Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oral Proteins and Peptides Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Oral Proteins and Peptides Sales Volume Market Share by Region (2015-2020)
3.2 Global Oral Proteins and Peptides Sales Revenue Market Share by Region (2015-2020)
3.3 North America Oral Proteins and Peptides Sales Volume
3.3.1 North America Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.3.2 North America Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Oral Proteins and Peptides Sales Volume
3.4.1 East Asia Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Oral Proteins and Peptides Sales Volume (2015-2020)
3.5.1 Europe Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Oral Proteins and Peptides Sales Volume (2015-2020)
3.6.1 South Asia Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Oral Proteins and Peptides Sales Volume (2015-2020)
3.7.1 Southeast Asia Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Oral Proteins and Peptides Sales Volume (2015-2020)
3.8.1 Middle East Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Oral Proteins and Peptides Sales Volume (2015-2020)
3.9.1 Africa Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Oral Proteins and Peptides Sales Volume (2015-2020)
3.10.1 Oceania Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Oral Proteins and Peptides Sales Volume (2015-2020)
3.11.1 South America Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.11.2 South America Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Oral Proteins and Peptides Sales Volume (2015-2020)
3.12.1 Rest of the World Oral Proteins and Peptides Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Oral Proteins and Peptides Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Oral Proteins and Peptides Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Oral Proteins and Peptides Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Oral Proteins and Peptides Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Oral Proteins and Peptides Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Oral Proteins and Peptides Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Oral Proteins and Peptides Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Oral Proteins and Peptides Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Oral Proteins and Peptides Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Oral Proteins and Peptides Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Oral Proteins and Peptides Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Oral Proteins and Peptides Sales Volume Market Share by Type (2015-2020)
14.2 Global Oral Proteins and Peptides Sales Revenue Market Share by Type (2015-2020)
14.3 Global Oral Proteins and Peptides Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Oral Proteins and Peptides Consumption Volume by Application (2015-2020)
15.2 Global Oral Proteins and Peptides Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Oral Proteins and Peptides Business
16.1 Allergan
16.1.1 Allergan Company Profile
16.1.2 Allergan Oral Proteins and Peptides Product Specification
16.1.3 Allergan Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Sanofi
16.2.1 Sanofi Company Profile
16.2.2 Sanofi Oral Proteins and Peptides Product Specification
16.2.3 Sanofi Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Generex Biotechnology
16.3.1 Generex Biotechnology Company Profile
16.3.2 Generex Biotechnology Oral Proteins and Peptides Product Specification
16.3.3 Generex Biotechnology Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 AstraZeneca
16.4.1 AstraZeneca Company Profile
16.4.2 AstraZeneca Oral Proteins and Peptides Product Specification
16.4.3 AstraZeneca Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Tarsa Therapeutics
16.5.1 Tarsa Therapeutics Company Profile
16.5.2 Tarsa Therapeutics Oral Proteins and Peptides Product Specification
16.5.3 Tarsa Therapeutics Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Biocon
16.6.1 Biocon Company Profile
16.6.2 Biocon Oral Proteins and Peptides Product Specification
16.6.3 Biocon Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Synthetic Biologics
16.7.1 Synthetic Biologics Company Profile
16.7.2 Synthetic Biologics Oral Proteins and Peptides Product Specification
16.7.3 Synthetic Biologics Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Synergy Pharmaceuticals
16.8.1 Synergy Pharmaceuticals Company Profile
16.8.2 Synergy Pharmaceuticals Oral Proteins and Peptides Product Specification
16.8.3 Synergy Pharmaceuticals Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Novo Nordisk
16.9.1 Novo Nordisk Company Profile
16.9.2 Novo Nordisk Oral Proteins and Peptides Product Specification
16.9.3 Novo Nordisk Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Hoffmann-La Roche
16.10.1 Hoffmann-La Roche Company Profile
16.10.2 Hoffmann-La Roche Oral Proteins and Peptides Product Specification
16.10.3 Hoffmann-La Roche Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Hovione
16.11.1 Hovione Company Profile
16.11.2 Hovione Oral Proteins and Peptides Product Specification
16.11.3 Hovione Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Novartis
16.12.1 Novartis Company Profile
16.12.2 Novartis Oral Proteins and Peptides Product Specification
16.12.3 Novartis Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Oral Proteins and Peptides Manufacturing Cost Analysis
17.1 Oral Proteins and Peptides Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Oral Proteins and Peptides
17.4 Oral Proteins and Peptides Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Oral Proteins and Peptides Distributors List
18.3 Oral Proteins and Peptides Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Oral Proteins and Peptides (2021-2026)
20.2 Global Forecasted Revenue of Oral Proteins and Peptides (2021-2026)
20.3 Global Forecasted Price of Oral Proteins and Peptides (2015-2026)
20.4 Global Forecasted Production of Oral Proteins and Peptides by Region (2021-2026)
20.4.1 North America Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.3 Europe Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.7 Africa Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.9 South America Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Oral Proteins and Peptides Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Oral Proteins and Peptides by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Oral Proteins and Peptides by Country
21.2 East Asia Market Forecasted Consumption of Oral Proteins and Peptides by Country
21.3 Europe Market Forecasted Consumption of Oral Proteins and Peptides by Countriy
21.4 South Asia Forecasted Consumption of Oral Proteins and Peptides by Country
21.5 Southeast Asia Forecasted Consumption of Oral Proteins and Peptides by Country
21.6 Middle East Forecasted Consumption of Oral Proteins and Peptides by Country
21.7 Africa Forecasted Consumption of Oral Proteins and Peptides by Country
21.8 Oceania Forecasted Consumption of Oral Proteins and Peptides by Country
21.9 South America Forecasted Consumption of Oral Proteins and Peptides by Country
21.10 Rest of the world Forecasted Consumption of Oral Proteins and Peptides by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer